Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Vericel (VCEL) Tops Q2 EPS by 41c, Revenue Beat; Raises FY19 Revenue Guidance
August 6, 2019 7:25 AM EDTVericel (NASDAQ: VCEL) reported Q2 EPS of ($0.05), $0.41 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $26.2 million versus the consensus estimate of $24.12 million.
Second Quarter 2019 Financial Highlights
Total net product revenues increased 38% to $26.2 million compared to $19.0 million in the second quarter of 2018;Gross margin of 66% compared to gross margin of 59% in the second quarter of 2018;Net loss of $19.8 million, or $0.45 per share, which includes the $17.5 million upfront license payment to MediWound for North American rights to NexoBrid®;Non-GAAP adjusted net loss, excluding the $17.5 million... More